Examples of using Lymerix in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Those patients vaccinated with LYMErix are unlikely to still be protected with the CDC.
Withdrawal was not met with much surprise considering the poor response to LYMErix.
Nevertheless, the intention of the LYMErix vaccine was to prevent the B. burgdorferi s. s.
Steere himself said in this latest interview that it may have been afinding by his own team that sparked fears about LYMErix, leading to its downfall.
Some court cases arose out of these reports of adverse effects from LYMErix and the Lyme disease vaccine's reputation was quickly tarnished.
LYMErix was exonerated by the FDA and CDC and allowed to continue to be sold but fears remained and patients began forming action groups and talking about suing the manufacturer.
Did Allen Steere inadvertently add weight to fears over LYMErix and autoimmune reactions?
Vaccines have progressed since LYMErix, with testing procedures also improving in order to aid clinicians in assessing an individual's response to the vaccine.
Steere embarked on a Phase III study to determine if autoimmunity andarthritis could be triggered by the LYMErix vaccine but found no evidence of such a reaction occurring.
Withdrawal of the LYMErix vaccine led to a hiatus on the research into a European Lyme disease vaccine and no company has since developed or introduced a viable alternative.
ImuLyme from Pasteur Merieux Connaught was not licenced in Canada or the US however, despite reports of it having a higher rate of prevention(92%)compared to LYMErix and fewer reports of adverse side-effects.
Some patients attempted to gain compensation from the LYMErix manufacturers by filing class action lawsuits and the high profile court cases tarnished the Lyme disease vaccine's reputation.
Interim results from a clinical trial suggest that a new Lyme disease vaccine is both safe and effective,offering hope of the first human vaccine for the disease since Lymerix was removed from the market in 2001.
LYMErix is the only vaccine ever to be withdrawn from sale voluntarily due to low public demand even when rates of disease continued to rise and approval was maintained by the FDA.
Allen Steere, who helped discover Lyme disease in 1977, said in a recent interview with CTV that he andhis team may have inadvertently fostered the panic around the LYMErix vaccine that resulted in it being pulled from the market by its manufacturers.
Those who remember the LYMErix affair will likely be watching closely to see how manufacturer of this new Lyme disease vaccine, Baxter, handle the publicity and promotion of their product.
A class action lawsuit was brought against the manufacturer SmithKline Beecham in 1999 claiming that those given the LYMErix vaccine were not warned about the possible consequences, particularly if they had a predisposition to autoimmune conditions and if they were already infected with Borrelia bacteria prior to vaccination.
In Canada, the LYMErix vaccine was voluntarily withdrawn at the same time as in the US(2002) although there was another vaccine in development at the same time as LYMErix which was thought to share similar success rates.
In 2001 concluded that there was no evidence showing the LYMErix vaccine had caused serious reactions or problems at a rate higher than any other vaccine currently approved and used in the US.
The fact that the LYMErix vaccine did not create immunity in the person themselves meant that questions were raised over how long it would remain effective and Steere was hoping to gather enough evidence after vaccinations took place to ascertain the need, if any, for booster shots.
The lessons learnt from LYMErix will no doubt have been taken on board by those companies looking at introducing a new Lyme disease vaccine, and with cases growing year on year there is certainly a major market for them to exploit.
However, the introduction of the LYMErix vaccine in the US was followed by considerable negative publicity as those receiving the vaccine claimed to have suffered serious immunological responses to it resulting in symptoms worse than Lyme disease itself.